This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

George F. Longstreth, MD; Ralph Green, MD

Arch Intern Med. 1983;143(5):902-904.

Abstract
• Hematologic studies, including serum and RBC folate assays, were done on 45 outpatients with chronic colitis who either took sulfasalazine (n=27) or did not use it (n=18). Overall, sulfasalazine users and nonusers had similar mean hemoglobin, hematocrit, serum folate, and RBC folate levels. However, within the drug users, RBC folate was inversely correlated with drug dose; serum folate was not. Patients taking 2 g or more of sulfasalazine daily had lower mean RBC folate levels (221.2±27.3 ng/mL) than patients either taking less (371.7±35.0 ng/mL) or nonusers (330.3±30.3 ng/mL). Mean corpuscular volume was also related to drug dose but not to RBC folate. Although maintenance sulfasalazine use rarely causes clinically significant folate deficiency, subclinical tissue depletion occurs as a dose-related effect.

{Arch Intern Med 1983;143:902-904)

Author Affiliations
From the Department of Medicine, Southern California Permanente Medical Group, San Diego (Dr Longstreth), and the Department of Basic and Clinical Research, Scripps Clinic and Research Foundation, La Jolla, Calif (Dr Green).

Footnotes
Accepted for publication Nov 22, 1982.

Reprint requests to Southern California Permanente Medical Group, 4647 Zion Ave, San Diego, CA 92120 (Dr Longstreth).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease
Heyman et al.
Am. J. Clin. Nutr. 2009;89:545-550.
ABSTRACT | FULL TEXT